Peak nasal inspiratory flow (PNIF) measurement was a feasible, noninvasive method for assessing nasal airflow obstruction in children with cystic fibrosis and correlated significantly with nasal ...

Following initiation of elexacaftor/tezacaftor/ivacaftor, Lung Clearance Index decreases in children with cystic fibrosis, ...

Please provide your email address to receive an email when new articles are posted on . Three measures of lung function improved between baseline and 12 months. Observed improvements were not as large ...

Vertex Pharmaceuticals dominates the market for cystic fibrosis drugs, but Sionna Therapeutics contends the pharma company’s products still have efficacy and safety limitations. Sionna has mapped out ...